Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Therapies for Maintaining GLP-1 Weight Loss
NCT07092618Phase 3Recruiting
- Sponsor
- AgelessRx
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin, sirolimus, naltrexone in obesity, Overweight, sponsored by AgelessRx. Started Dec 2024; status: recruiting.
02
Drugs
metforminsirolimusnaltrexone
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07092618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092618.